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lonising radiation has been acknowledged as an effective
carcinogen for several decades but the nature of the primary
lesions in the DNA of exposed cells which cause them to
undergo oncogenic transformation is not known. It is
generally agreed that oncogenic transformation is a multi-
stage process (Barrett & Fletcher, 1987) at the very least
requiring the interaction of two events: an 'initiation' and a
'promotion' event. These may take the form of, for example,
the activation or abnormal expression of more than one
oncogene, such as c-ras and c-myc (e.g. Balmain & Pragnell,
1983; Balmain, 1985), or the activation of a mutated
oncogene (Burck et al., 1988; Bradshaw, 1986). For in vivo
systems the complex nature of the process is indicated by the
multiplicity of factors influencing the outcome of initial
treatments (e.g. Fry, 1981; Upton, 1984). Although the essen-
tial nature of the transformation process is not yet under-
stood it is a frequent observation that karyotypic changes,
particularly translocations, have taken place in transformed
cells (e.g. the Philadelphia chromosome in chronic myeloid
leukaemia) which may be causally related to the transforma-
tion process (Klein & Klein, 1984). Oncogenic transforma-
tion of cultured cells can be studied in the murine C3H 10T1/
2 system (Reznikoff et al., 1973; Han & Elkind, 1979; Ken-
nedy et al., 1980). The 10T1/2 system may not be an ideal
system as a model for the study of cancer induction in the
whole animal. However, it is one of the few test systems
available for agents or factors which are known carcinogens
in animals or humans. Transformation of 10T1/2 cells from
the 'normal' cell phenotype to foci of uncontrolled cell
growth allows the quantification of the effects of radiation or
other genotoxic agents. These foci of rapid growth (type III
foci) can be shown to yield malignant tumours in syngeneic
mice after subcutaneous inoculation of a sufficient number of
cells.
Although it has been possible to obtain dose-effect rela-
tionships for induction of transformed foci as a function of
radiation dose, the mechanisms of induction of these by
radiation are not yet understood. In particular it has not
been possible to identify the primary lesion or lesions respon-
sible for the genetic alterations of transformed cells.
One of the main problems is that ionising radiation
induces several different types of initial lesions in the DNA of
exposed cells. These are direct DNA strand breaks (single or
double), base lesions, and cross-links between strands of
DNA or between DNA and protein. For several radiation-
damage end-points, in eukaryotic cells (e.g. cell death,
chromosome aberrations and mutations) the DNA double-
strand break (dsb) has been implicated as the causative lesion
(Frankenberg et al., 1984; Natarajan et al., 1980). Moreover,
it has been shown that exposure of permeabilised mammalian
cells to type II restriction endonucleases (RE) which induce
double-strand breaks in DNA at specific recognition
sequences leads to the induction of chromosomal aberrations
(for a review see Bryant, 1988). It was shown previously that
RE, which induce 'blunt-ended' dsb, were more effective than
those inducing cohesive-ended dsb (Bryant, 1984). In these
studies entry of RE was facilitated by the simultaneous
exposure of Chinese hamster cells to inactivated Sendai virus
and RE. Murine cells were also shown to be susceptible to
this treatment (Natarajan & Obe, 1984), and in both hamster
and mouse cells aberrations were observed of the same types
as those induced by X-rays, including both exchanges and
deletions (Bryant, 1984; Natarajan & Obe, 1984). On the
basis of the observation that visible chromosomal alterations
are often associated with cancers in man and other mammals
(Klein & Klein, 1984), it seemed plausible that an initiating
lesion in radiogenic cancers might be the DNA dsb. In
addition it has been observed that restriction endonuclease
induced dsb lead to mutations at the hgprt locus in Chinese
hamster cells (Obe et al., 1986). Mutations were not induced
at the NA+/K+ ATPase locus by the same treatment, and
the reason is thought to be that this type of genetic change
involves a point mutation rather than a 'chromosomal' muta-
tion as in the case of the hgprt locus.
In the light of the foregoing evidence we have examined
the possibility that oncogenic transformation can be induced
by treatment of Sendai virus permeabilised 10T1/2 cells with
the restriction endonuclease Pvu II which induces blunt-
ended dsb at the sequence CAG'GTC; a procedure known to
lead to induction of chromosomal aberrations in hamster
cells (Bryant, 1984).
Low passage C3HlOTl/2 cells were cultured in basal
Eagle's medium with addition of 10% fetal calf serum
(BMEFCS). Cells were seeded into 75 cm2 flasks at approx-
imately I05 cells per flask and grown for 3 days, when they
were sub-confluent. From this culture, 25 cm2 experimental
flasks were seeded from this culture at 2 x 105 cells per flask,
and these were incubated for a further 3 days, so that cells
were still sub-confluent. For enzyme treatments, medium was
aspirated from flasks and the cell layers rinsed once with
Hank's balanced salts solution (HBSS) containing I% bovine
serum albumin and 6 mmol 1 ' MgCl2. This solution was
aspirated and 300fsl of ice-cold UV-inactivated Sendai virus
(ISV), containing approximately 1200 HAU ml-', was added
together with various amounts of Pvu II and flasks placed on
ice for 10 min. After this, flasks were transferred to an
incubator at 37°C for 30 min. During incubations flasks were
tilted from side to side at intervals to ensure that the virus/
enzyme mixture was evenly dispersed over the cell layer.
After treatment the liquid was aspirated and cells rinsed once
with 2 ml of warm BMEFCS and 5 ml of BMEFCS added to
each flask and placed in an incubator at 37°C for 3-4 h.
Both colony forming ability and transformation assays
were performed on each treated flask. Cells were trypsinised
and counted. For the colony assay approximately 100 viable
cells were plated in each of four 10 cm dishes with 10 ml
BMEFCS and incubated for 10-14 days. For the transfor-
mation assay, 300 surviving cells were plated in each of 30
flasks (75 cm2) and incubated for 8 weeks with weekly
medium changes. After cells became confluent the serum
content was reduced to 5%. Medium was aspirated and cells
rinsed in Sorensen's buffer (pH 6.4) and then cells were fixed
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in methanol for 10 min. Cells were finally stained in 3%
Giemsa for 30 min, rinsed with buffer and allowed to dry.
Scoring of transformed foci was carried out according to
the classification of Reznikoff et al. (1973). Mean frequencies
of transformed foci were determined from the frequency of
negative flasks by assuming a Poisson distribution according
to the method of Han and Elkind (1979).
The same types of transformed foci were observed as those
induced by ionising radiation and these were classified into
types I, II and III. An example of a Pvu II induced focus is
shown in Figure 1, illustrating the characteristic multi-
layering and criss-cross patterning. The combined frequency
of type II and III foci was determined in control (untreated),
enzyme storage buffer and virus treated (SB) and Pvu II
treated samples. The results are presented in Tables I and II.
These show that a significantly higher number of transformed
foci were observed in samples of cells treated at the highest
enzyme dose (300 U ml-'). Although the increase in transfor-
mation frequency was small in the enzyme treated group it
was significantly different from the storage buffer and inac-
tivated virus treated (ISV + SB) control. Using a x2 test
(Parker, 1979), comparing the number of positive flasks in
the Pvu II treated with the number of positive flasks in the
ISV + SB group, there was a significant difference (X2 correla-
tion = 4.70, P<0.05; Table I). A similar conclusion is
reached by calculating the standardised normal deviate
(d= 2.00, P<0.05) for the two Poisson counts (Parker,
1979). Comparing the results of the transformation frequency
Table I Frequencies of positive (presence of type II or III foci) and
negative flasks in Pvu II treated samples
No. No. Total Fraction Average
+ ve -ve no. flasks transformantsl
Treatment flasks flasks flasks -ve (F) flask (ATF)
Control 13 106 119 0.891 0.1157
ISV + SB I1 109 120 0.908 0.0961
ISV + 150
(U ml-') 13 104 117 0.889 0.1178
ISV + 300
(U ml-') 24 97 121 0.802 0.2211
Pvu II concentration is given in U ml-'. Pooled results from four
independent experiments. SB, storage buffer; ISV, inactivated Sendai
virus; F, fraction of flasks with no transformed foci; ATF, average
number oftransformants per flask calculated from (- In, F) assuming
Poisson statistics (Han & Elkind, 1979).
(TF1; Table II) for individual experiments using a t test also
suggests there is a significant difference (t = 2.29, P<O.05;
Table II).
Table II Transformation frequencies per viable cell (TF) calculated
from data in Table I
Treatment TFI (x 10'4) TF2 (x 10-4)
Control 3.56 + 1.34 3.86
ISV+SB 3.11 1.36 3.20
ISV + 150 (U ml) 3.52 1.10 3.93
ISV+300(Uml-') 7.16 1.14 7.37
Pvu II concentration is given in U ml-'. Pooled results from four
independentexperiments. TF1, transformingfrequencycalculatedfrom
the observed number of transformants per flask (mean + s.e.; four
separateexperiments); TF2,transformingfrequencycalculatedfromthe
number of negative flasks (see Table I); SB, storage buffer; ISV,
inactivated Sendai virus.
At the highest enzyme dose used (300 U ml-1) there was
only a small effect on cell survival (surviving frac-
tion = 0.91 ± 0.09) compared to untreated controls. The sur-
viving fraction for the ISV + SB group was 0.94 ± 0.06. It is
pertinent to note that IOTI/2 cells exhibit a prominent
shoulder on the survival curve following X-ray treatment. A
similar transformation frequency has been observed at radia-
tion doses of about 2 Gy (Han & Elkind, 1979; Kolman et
al., 1989; Terzaghi & Little, 1976) where the cell survival is
also only slightly decreased from controls (surviving frac-
tion = 0.8-0.9).
The results thus show a significantly higher frequency of
transformation in samples treated with Pvu II at 300 U ml-'
than in control or storage-buffer treated groups. We infer from
thisresultthatoneoftheeventsintheoncogenictransformation
ofcellsmaybeone ormore DNAdsb. Themechanismbywhich
dsb might be involved in oncogenic transformation is not
known but could entail non-repair or misrepair (e.g. transloca-
tion) of dsb. Both chromosomal aberrations of exchange and
deletion types, and mutations at the hgprt locus have been
shown to arise in restriction endonuclease treated cells (Bryant,
1984; Obeetal., 1986). Itisthereforepossiblethattheoncogenic
transformation of lOT1/2 cells could result from such
cytogenetic alterations or via mutation. Experiments to deter-
mine the frequency of chromosomal aberrations induced by
Pvu II and other restriction enzymes, e.g. those producing
cohesive rather than blunt-ended dsb in 1OT1/2 cells, are in
progress. The nature of the oncogenic change involved in
.,-
Figure 1 The edge of a type III focus induced by Pvu II, showing the multilayering and 'criss-cross' appearance at the edges of the
focus. This contrasts with the normal monolayer formed at confluence by 1OT1/2 cells, which can be seen outside the focus.854 P.E. BRYANT & A.C. RICHES
transformation of IOTI/2 cells is not yet clear. The oncogene
c-myc is known to be expressed in transformed foci. However,
the presence ofamutated c-ras genehasnotbeen demonstrated
sofar(Saweyetal., 1988). Boreketal. (1987)havedemonstrated
the presence ofa unique non-ras transforming gene in cell lines
derived from irradiated hamster embryo cells and mouse
C3H 10 T1/2 cells.
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